Markets
BSE See NSE See 47,705.80
-243.62 (-0.51%)
Kerbside

Kerbside

Print

The recommendations provided in this column are taken from various market sources such as brokers, analysts, dealers and investment strategists, etc. These recommendations may not be backed by strong fundamentals. Therefore we advise readers to use their own discretion before investing in these recommendation

 

To read the entire article, you must be a DSIJ magazine subscriber.

 

 

Comments are only visible to subscribers.

DSIJ Mindshare

Caplin Point subsidiary gets USFDA approval for Milrinone Lactate injection

Ganesh V / Article rating: 4.5

Caplin Point Laboratories Limited announced on Monday after the market hours that its subsidiary company, Caplin Steriles Limited, has been granted final approval from United States Food & Drug Administration (USFDA) for its abbreviated new drug application (ANDA) Milrinone Lactate injection. 

1345Last